Amgen (AMGN) Revenue — Quarter Ended Sep 30, 2023
Revenue declined from the prior quarter but rose compared to the same quarter a year earlier. The year-over-year increase reflects continued growth, while the sequential decrease signals a temporary pullback.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue declined from the prior quarter but rose compared to the same quarter a year earlier. The year-over-year increase reflects continued growth, while the sequential decrease signals a temporary pullback.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$6.9B
Revenue reported for this quarter.
Quarter-over-quarter
-1.2%
Change from the immediately preceding quarter.
Year-over-year
+3.8%
Change from the comparable year-ago quarter.
Trailing four quarters
$26.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $6.8B | -0.1% |
| Mar 31, 2023 | $6.1B | -2.1% |
| Jun 30, 2023 | $7B | +5.9% |
| Sep 30, 2023 | $6.9B | +3.8% |
Revenue performance
The reported revenue moved lower from the preceding quarter, yet it was higher than the same period one year prior. The mixed performance suggests a quarter-over-quarter softening against a stronger year-over-year comparison.
Quarterly comparison
Compared with the immediately preceding quarter, revenue decreased. In contrast, revenue was up when measured against the same quarter one year ago.
What to watch
The filing highlights uncertain macroeconomic conditions, including inflation and rising interest rates, as ongoing challenges to the business.